Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence Rooney
KYMR•Form 3 filing names new chief medical officer
Kymera Therapeutics named Terence Rooney as chief medical officer in a Form 3 filing dated July 27, 2026.
